首页> 外文期刊>Expert review of pharmacoeconomics & outcomes research >Autism spectrum disorders: A review of measures for clinical, health services and cost-effectiveness applications
【24h】

Autism spectrum disorders: A review of measures for clinical, health services and cost-effectiveness applications

机译:自闭症谱系障碍:临床,健康服务和成本效益应用措施的综述

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Autism spectrum disorders (ASDs) are characterized by impairments in social interaction, communication and behavioral functioning that can affect the health-related quality-of-life outcomes of the affected child and the family. ASDs have increased in prevalence, leading to a demand for improved understanding of the comparative effectiveness of different pharmacologic, behavioral, medical and alternative treatments for children as well as systems for providing services. This review describes outcome instruments that can be used for clinical, health services and cost-effectiveness applications. There is a pressing need to identify the most appropriate instruments for measuring health-related quality-of-life outcomes in this population. Studies evaluating the cost-effectiveness of interventions or treatments for children with ASDs using the cost per quality-adjusted life year metric are lacking. Researchers have the potential to contribute greatly to the field of autism by quantifying outcomes that can inform optimal treatment strategies.
机译:自闭症谱系障碍(ASD)的特征是社交互动,沟通和行为功能受损,可能影响受影响儿童和家庭与健康相关的生活质量。自闭症的患病率增加,导致需要更好地了解儿童的不同药理,行为,医学和替代疗法以及提供服务的系统的相对有效性。这篇综述描述了可用于临床,健康服务和成本效益应用的结果工具。迫切需要找到最合适的工具来衡量该人群与健康相关的生活质量结果。缺乏使用每质量调整生命年的成本指标评估对自闭症儿童进行干预或治疗的成本效益的研究。研究人员有可能通过量化可指导最佳治疗策略的结果来为自闭症领域做出巨大贡献。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号